Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.
Qi J, Choi I, Ota S, Ichikawa S, Fujishima N, Iida H, Sugiura I, Sugiura K, Murata Y, Inoue H, Ohwada S, Wang J. Qi J, et al. Among authors: inoue h. Clin Pharmacol Drug Dev. 2024 May;13(5):560-571. doi: 10.1002/cpdd.1353. Epub 2024 Jan 29. Clin Pharmacol Drug Dev. 2024. PMID: 38284515 Clinical Trial.
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors.
Tsutsumi H, Inoue H, Shiraishi Y, Hirayama A, Nakanishi T, Ando H, Nakajima M, Shinozaki S, Ogata H, Okamura K, Kimura S, Ogawa T, Ota K, Yoneshima Y, Tanaka K, Hamada N, Okamoto I, Iwama E. Tsutsumi H, et al. Among authors: inoue h. Lung Cancer. 2023 Jul;181:107264. doi: 10.1016/j.lungcan.2023.107264. Epub 2023 Jun 2. Lung Cancer. 2023. PMID: 37276707
Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer.
Ikeuchi N, Igata F, Kinoshita E, Kawabata T, Tan I, Osaki Y, Otsuka R, On R, Ikeda T, Nakao A, Sasaki T, Aoyama T, Hirano R, Harada T, Ebi N, Fujita M, Inoue H. Ikeuchi N, et al. Among authors: inoue h. Anticancer Res. 2023 Feb;43(2):713-724. doi: 10.21873/anticanres.16210. Anticancer Res. 2023. PMID: 36697078
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).
Takimoto R, Kamigaki T, Ito H, Saito M, Takizawa K, Soejima K, Yasuda H, Ohgino K, Terai H, Tomita K, Miura M, Mizukoshi E, Miyashita T, Nakamoto Y, Hayashi K, Miwa S, Kitahara M, Takeuchi A, Kimura H, Mochizuki T, Sugie H, Seino KI, Yamada T, Takeuchi S, Makita K, Naitoh K, Yasumoto K, Yoshida Y, Inoue H, Kotake K, Ohshima K, Noda SE, Okamoto M, Yoshimoto Y, Okada S, Ibe H, Oguma E, Goto S; CITEG. Takimoto R, et al. Among authors: inoue h. Cytotherapy. 2023 Nov;25(11):1229-1235. doi: 10.1016/j.jcyt.2023.06.007. Epub 2023 Jul 22. Cytotherapy. 2023. PMID: 37486281 Free article.
Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA study.
Perez-Alamino R, Maldonado-Ficco H, Moltó A, Waimann C, Maldonado-Cocco J, Dougados M, Landewé R, van der Heijde D, Van den Bosch F; ASAS-COMOSPA study. Perez-Alamino R, et al. RMD Open. 2025 Jan 31;11(1):e004756. doi: 10.1136/rmdopen-2024-004756. RMD Open. 2025. PMID: 39890204 Free article.
The first complete hand-rearing of two neonatal finless porpoises.
Kasamatsu M, Hasegawa K, Wakabayashi I, Furuta M, Inoue H, Iwano H. Kasamatsu M, et al. Among authors: inoue h. PLoS One. 2025 Jan 30;20(1):e0288891. doi: 10.1371/journal.pone.0288891. eCollection 2025. PLoS One. 2025. PMID: 39883650 Free PMC article.
6,574 results